EHRA Premium Access

Rationale behind development of novel drugs for atrial arrhythmias

Congress Presentation

About the speaker

Associate Professor Jordi Heijman

Faculty of Health, Medicine and Life Sciences Maastricht University, Maastricht (Netherlands (The))
7 presentations
0 follower

4 more presentations in this session

The trials-and-errors of antiarrhythmic drug therapy

Speaker: Professor J. Camm (London, GB)


Genetic basis for tailored drug therapy for ventricular arrhythmias

Speaker: Associate Professor C. Remme (Amsterdam, NL)


Antiarrhythmic drugs - What, why, when to whom

Speaker: Professor G. Dan (Bucharest, RO)


Panel discussion


Access the full session

Critical appraisal of antiarrhythmic drug therapy - The science behind trial-and-error

Speakers: Associate Professor J. Heijman, Professor J. Camm, Associate Professor C. Remme, Professor G. Dan

About the event


EHRA 2019

17 March - 19 March 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb